The effect of dichlorvos treatment on butyrylcholinesterase activity and lipid metabolism in rats

Arhiv za Higijenu Rada i Toksikologiju

Volumn 53, Issue 4, 2002, Pages 275-281

  Lucić, Ana ^a   Bradamante, Vlasta ^b   Radić, Božica ^a   Peraica, Maja ^a   Domijan, Ana Marija ^a   Fuchs, Radovan ^a   Stavljenić Rukavina, Ana ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

BuChE; DDVP; HDL cholesterol; LDL cholesterol; Total cholesterol; Triglycerides

Indexed keywords

CHOLESTEROL; CHOLINESTERASE; DICHLORVOS; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DICHLORVOS; FEMALE; LIPID METABOLISM; MALE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0038007912     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Vandekar M. Minimizing occupational exposure to pesticides: cholinesterase determination and organophosphorus poisoning. Res Rev 1980;75:67-80.
2. Lockridge O, Masson P. Pesticides and susceptible populations: People with buthyrylcholinesterase genetic variants may be at risk. Neurotoxicology 2000;21:113-26.
3. Ballantyne FC. Histocemical and biochemical aspects of cholinesterase activity of adipose tissue. Arch Int Pharemacodyn 1968;173:348-9.
4. Kutty KM. Biological function of cholinesterase. Clin Biochem 1980;13:239-43.
5. Graybiel AM, Ragsdale CW Jr. Pseudocholinesterase staining in the primary visual pathway of the macaque monkey. Nature 1982;299:439-42.
6. Kutty KM, Annanpurna V, Prabhakaran V. Pseudocholinesterase: A protein with functions unrelated to its name. Biochem Soc Trans 1989;7:555-6.
7. Kutty KM, Payne RH. Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J Clin Lab Anal 1994;8:247-50.
8. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity in vitro and in vivo quantitative characterization. Biochem Pharmacol 1993;45:2465-74.
9. Brandeis R, Raveh L, Grunwald J, Cohen E, Ashani Y. Prevention of soman-induced cognitive deficits by pretreatement with human butyrylcholinesterase in rats. Pharmacol Biochem Behav 1993;46:889-96.
10. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV. Protection by butyrylcholinesterase against organophosphorus poisoning in non-human primates. J Pharmacol Exp Ther 1991;259:633-8.
11. Kutty KM, Redheendran R, Murphy D. Serum cholinesterase: Function in lipoprotein metabolism. Experientia 1977;33:420-1.
12. Krnid Z, Bradamante V. Effects of Oxprenolol treatment on pseudocholinesterase and lipids in rats. Arzneim Forsch Drug Res 1997;47:910-3.
13. Kutty KM, Jacob JC, Hutton CJ, Davis PJ, Peterson SC. Serum beta-lipoproteins: studies in a patient and Guinea pigs after the ingestion of organophosphorus compounds. Clin Biochem 1975;8:379-83.
14. Cucuianu M, Popescu TA, Haragus ST. Pseudocholinesterase in obese and hyperlipemic subjects. Clin Chim Acta 1968;22:151-5.
15. Ryhanen R, Herranen J, Korhonen K, Penttila I, Polvilampi M, Puhakainen E. Relationship between serum lipids, lipoproteins and pseudocholinesterase during organophosphate poisoning in rabbits. Int J Biochem 1984;16:687-90.
16. Chu AI, Fontaine P, Kutty KM, Murphy D. Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients. Clin Chim Acta 1978;85:55-9.
17. Schouten JA, Mulder C, Beynen AC. Pseudocholinesterase and serum lipoproteins. Atheroschlerosis 1987;67:269-70.
18. Kutty KM, Jain R, Peper C. Cholinesterase activity in the serum and liver of Zucker fat rats and controls. Nutr Res 1984;4:99-104.
19. Annapurna V, Senciall I, Davis AJ, Kutty KM. Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats. Diabetologia 1991;34:320-4.
20. Hardman JG, Limbird LE, Malinoff PB, Ruddon RW. Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York; 1996.
21. Williams BR. Metrifonate: A new agent for the treatment of Alzheimer's disease. Am J Health-Syst Pharm 1999;56:427-32.
22. Kozlowska A, Sadurska B, Szymczyk T. Effect of dichlorvos on the activity of lipoprotein lipase from adipose tissue, on plasma lipids and postheparin lipolytic plasma activity in rats. Arch Toxicol 1988;62:227-9.
23. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
24. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:350-6.
25. Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Z Kin Chem Klin Biochem 1974;12:223-6.
26. Koditscheck LK, Umbreit WW. Alpha-glycerophosphate oxidase in Streptococcus faecium F 24. J Bacteriol 1969;98:1063-8.
27. Bucolo G, David H. Quantitative determination of serum triglyceride by the use of enzyime. Clin Chem 1973;19:476-82.
28. Burstein M, Scholnick HR, Martin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-7.
29. Friedewald WF, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
30. Tall AR. Plasma high-density lipoproteins. J Clin Invest 1990;86:379-84.
31. Goldberg IJ, Le NA, Paterniti JR, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the Cynomolgus monkey. J Clin Invest 1982;70:1184-92.